Atkinson, M A; Chervonsky, A (2012) Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55:2868-77
|
Thompson, James A; Perry, Daniel; Brusko, Todd M (2012) Autologous regulatory T cells for the treatment of type 1 diabetes. Curr Diab Rep 12:623-32
|
Hulme, Maigan A; Wasserfall, Clive H; Atkinson, Mark A et al. (2012) Central role for interleukin-2 in type 1 diabetes. Diabetes 61:14-22
|
Brusko, Todd M; Wasserfall, Clive H; Hulme, Maigan A et al. (2009) Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. PLoS One 4:e7980
|
Brusko, Todd; Wasserfall, Clive; McGrail, Kieran et al. (2007) No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56:604-12
|
Lee, Chul-Ho; Chen, Yi-Guang; Chen, Jing et al. (2006) Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis. Diabetes 55:171-8
|
Brusko, Todd M; Wasserfall, Clive H; Agarwal, Anupam et al. (2005) An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol 174:5181-6
|
Brusko, Todd M; Wasserfall, Clive H; Clare-Salzler, Michael J et al. (2005) Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54:1407-14
|
Lee, Chul-Ho; Reifsnyder, Peter C; Naggert, Jurgen K et al. (2005) Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis. Diabetes 54:2525-32
|
You, Sylvaine; Chen, Cyndi; Lee, Wen-Hui et al. (2004) Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J Immunol 173:6777-85
|
Showing the most recent 10 out of 18 publications